tradingkey.logo
tradingkey.logo
Pesquisar

Medifast Inc

MED
Adicionar à lista de desejos
11.010USD
-0.020-0.18%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
121.87MValor de mercado
PerdaP/L TTM

Mais detalhes de Medifast Inc Empresa

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Informações de Medifast Inc

Código da empresaMED
Nome da EmpresaMedifast Inc
Data de listagemDec 30, 1993
CEOChard (Daniel R)
Número de funcionários504
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 30
Endereço100 International Drive, 18th Floor
CidadeBALTIMORE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal21202
Telefone14105818042
Sitehttps://medifastinc.com/
Código da empresaMED
Data de listagemDec 30, 1993
CEOChard (Daniel R)

Executivos da empresa Medifast Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
242.04K
+31.85%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.53K
+47.62%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.40K
+35.00%
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Scott D. Schlackman
Mr. Scott D. Schlackman
Independent Director
Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Nicholas M. Johnson
Mr. Nicholas M. Johnson
Chief Field Operations Officer
Chief Field Operations Officer
--
--
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
242.04K
+31.85%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.53K
+47.62%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.40K
+35.00%
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Scott D. Schlackman
Mr. Scott D. Schlackman
Independent Director
Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Medifast Inc?

Os cinco principais acionistas de Medifast Inc são: Mr. Daniel R. (Dan) Chard

Quantas instituições possuem ações da Medifast Inc (MED)?

Em 2026Q1, 401 instituições possuíam ações da Medifast Inc, com valor de mercado aproximado de 9.25M, representando 83.21% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -4364386.00.